Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chugai Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥12.46T | 30.4x | 1.18 | JP¥7,583 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.5% Upside | Upgrade to Pro+ | |
Takeda Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥6.81T | 63.7x | -2.4 | JP¥4,357 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.5% Upside | Upgrade to Pro+ | |
Daiichi Sankyo | Tokyo | Healthcare | Pharmaceuticals | JP¥6.16T | 21.1x | 0.44 | JP¥3,299 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Otsuka Holdings Ltd | Tokyo | Healthcare | Pharmaceuticals | JP¥3.75T | 10.9x | 0.07 | JP¥7,099 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 33.6% Upside | Upgrade to Pro+ | |
Astellas Pharma Inc. | Tokyo | Healthcare | Pharmaceuticals | JP¥2.48T | 48.8x | 0.25 | JP¥1,385 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22.9% Upside | Upgrade to Pro+ | |
Shionogi | Tokyo | Healthcare | Pharmaceuticals | JP¥2.16T | 12.7x | 1.66 | JP¥2,546 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -1.2% Downside | Upgrade to Pro+ | |
Kyowa Kirin | Tokyo | Healthcare | Pharmaceuticals | JP¥1.3T | 25.4x | -0.68 | JP¥2,474.50 | -0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1% Upside | Upgrade to Pro+ | |
Eisai | Tokyo | Healthcare | Pharmaceuticals | JP¥1.13T | 24.5x | 2.24 | JP¥4,027 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.4% Upside | Upgrade to Pro+ | |
Ono Pharmaceutical Ltd | Tokyo | Healthcare | Pharmaceuticals | JP¥720.4B | 14.4x | -0.24 | JP¥1,535 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.9% Upside | Upgrade to Pro+ | |
Santen Pharmaceutical Co Ltd | Tokyo | Healthcare | Pharmaceuticals | JP¥568.71B | 16x | 0.37 | JP¥1,660 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.8% Upside | Upgrade to Pro+ | |
Medipal Holdings Corp | Tokyo | Healthcare | Pharmaceuticals | JP¥479.92B | 11.9x | -8.85 | JP¥2,318.50 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.9% Upside | Upgrade to Pro+ | |
Rohto Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥462.1B | 15x | 85.67 | JP¥2,047 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 33.9% Upside | Upgrade to Pro+ | |
Suzuken Co Ltd | Tokyo | Healthcare | Pharmaceuticals | JP¥372.88B | 11.4x | 0.4 | JP¥5,202 | -0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4.9% Upside | Upgrade to Pro+ | |
Sumitomo Dainippon Pharma | Tokyo | Healthcare | Pharmaceuticals | JP¥365.51B | 15.5x | 0.15 | JP¥922 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -33.3% Downside | Upgrade to Pro+ | |
Hisamitsu Pharmaceutical Inc | Tokyo | Healthcare | Pharmaceuticals | JP¥295.43B | 13.7x | 0.22 | JP¥4,048 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19% Upside | Upgrade to Pro+ | |
Toho Holdings | Tokyo | Healthcare | Pharmaceuticals | JP¥288.81B | 14.7x | -16.16 | JP¥4,606 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -4.8% Downside | Upgrade to Pro+ | |
Tsumura & Co | Tokyo | Healthcare | Pharmaceuticals | JP¥252.73B | 7.9x | 0.08 | JP¥3,387 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.5% Upside | Upgrade to Pro+ | |
Nippon Shinyaku | Tokyo | Healthcare | Pharmaceuticals | JP¥210.02B | 6.4x | 0.25 | JP¥3,121 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25% Upside | Upgrade to Pro+ | |
Sawai Group Holdings Co | Tokyo | Healthcare | Pharmaceuticals | JP¥208.39B | 17x | 0.1 | JP¥1,807 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29.3% Upside | Upgrade to Pro+ | |
Torii Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥177.42B | 32x | 6.28 | JP¥6,320 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -33.5% Downside | Upgrade to Pro+ | |
Kissei Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥166.36B | 14.6x | 1.25 | JP¥4,020 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.4% Upside | Upgrade to Pro+ | |
Towa Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥146.75B | 7.7x | 0.45 | JP¥2,997 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 39.8% Upside | Upgrade to Pro+ | |
Kaken Pharmaceutical Co Ltd | Tokyo | Healthcare | Pharmaceuticals | JP¥143.81B | 10.4x | 0.14 | JP¥3,801 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.7% Upside | Upgrade to Pro+ | |
Mochida Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥104.19B | 18.3x | 0.69 | JP¥2,950 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Zeria Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥91.82B | 9.2x | 0.32 | JP¥2,079 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 40% Upside | Upgrade to Pro+ | |
Kyorin Holdings Inc | Tokyo | Healthcare | Pharmaceuticals | JP¥86.63B | 9.5x | 0.13 | JP¥1,508 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -13.2% Downside | Upgrade to Pro+ | |
Nxera Pharma | Tokyo | Healthcare | Pharmaceuticals | JP¥82.44B | -35.6x | -0.46 | JP¥915 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Katakura Industries | Tokyo | Healthcare | Pharmaceuticals | JP¥72.18B | 19x | 0.56 | JP¥2,298 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ASKA Pharmaceutical Holdings Co | Tokyo | Healthcare | Pharmaceuticals | JP¥69.07B | 13.5x | -0.41 | JP¥2,442 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.2% Upside | Upgrade to Pro+ | |
JCR Pharmaceuticals | Tokyo | Healthcare | Pharmaceuticals | JP¥62.14B | -13.3x | 0.07 | JP¥514 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.8% Upside | Upgrade to Pro+ | |
Vital Ksk Holdings | Tokyo | Healthcare | Pharmaceuticals | JP¥57.64B | 8x | 0.26 | JP¥1,196 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cuorips | Tokyo | Healthcare | Pharmaceuticals | JP¥47.75B | -72.7x | -11.86 | JP¥5,780 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Fuji Pharma Co Ltd | Tokyo | Healthcare | Pharmaceuticals | JP¥34.69B | 10.9x | -0.22 | JP¥1,416 | 6.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Seikagaku Corp | Tokyo | Healthcare | Pharmaceuticals | JP¥33.35B | 27.4x | -0.62 | JP¥609 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Daito Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥29.57B | 13.9x | -0.43 | JP¥986 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.6% Downside | Upgrade to Pro+ | |
Koa Shoji | Tokyo | Healthcare | Pharmaceuticals | JP¥28.39B | 7.7x | 0.38 | JP¥682 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Renascience | Tokyo | Healthcare | Pharmaceuticals | JP¥25B | 158.1x | 1.54 | JP¥1,946 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CanBas | Tokyo | Healthcare | Pharmaceuticals | JP¥21.12B | -13.9x | 0.51 | JP¥1,094 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
StemRIM | Tokyo | Healthcare | Pharmaceuticals | JP¥19.82B | -1.2 | JP¥316 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Astena Holdings | Tokyo | Healthcare | Pharmaceuticals | JP¥19.06B | -8.4x | 0.04 | JP¥473 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Fuso Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥17.93B | 6.4x | 0.06 | JP¥2,116 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CellSeed | Tokyo | Healthcare | Pharmaceuticals | JP¥16.5B | -9.9x | JP¥472 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
ReproCell | Tokyo | Healthcare | Pharmaceuticals | JP¥16.1B | 154.1x | 0.39 | JP¥171 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oncolys Biopharma | Tokyo | Healthcare | Pharmaceuticals | JP¥16.08B | -7x | -0.54 | JP¥653 | 3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Taiko Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥16.06B | 22.2x | 0.18 | JP¥322 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ohki Healthcare | Tokyo | Healthcare | Pharmaceuticals | JP¥14.51B | 5.5x | 0.27 | JP¥1,061 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Stella Pharma | Tokyo | Healthcare | Pharmaceuticals | JP¥13.72B | -78.9x | -1.18 | JP¥394 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
RaQualia Pharma | Tokyo | Healthcare | Pharmaceuticals | JP¥13.59B | -28.6x | 0.5 | JP¥554 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cellsource | Tokyo | Healthcare | Pharmaceuticals | JP¥13.55B | 22.2x | JP¥676 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 28.7% Upside | Upgrade to Pro+ | ||
Wakamoto Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥10.65B | -46.7x | JP¥306 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |